Sierra Leone: New Ebola Case Prompts Use of Experimental Vaccine - UN
[UN News] The detection of a new case of Ebola in Sierra Leone over the weekend after the West African country had marked almost three weeks of zero cases has prompted the use of an experimental vaccine to fight the disease, according to the United Nations World Health Organization (WHO). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 3, 2015 Category: African Health Source Type: news

Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for...
Venice provides a transformative window into greed, revenge and survival in a compelling debut novel that introduces readers to Pepper McCallan, a consultant to the U.S. Counterterrorism Agency.(PRWeb September 01, 2015)Read the full story at http://www.prweb.com/releases/Ebola-Vaccine-Wars/Alexi-Venice/prweb12925456.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 2, 2015 Category: Pharmaceuticals Source Type: news

CDC caught wildly overestimating disease epidemic fatality numbers to boost vaccine sales
(NaturalNews) Arrogance and egoism run rampant within the ranks of the Centers for Disease Control and Prevention (CDC), where deluded statistical modelers acting on behalf of the pharmaceutical and vaccine industries routinely over hype disease outbreaks like the Ebola scare (and... (Source: NaturalNews.com)
Source: NaturalNews.com - September 2, 2015 Category: Consumer Health News Source Type: news

New Ebola case in Sierra Leone prompts expansion of experimental vaccine trial – UN health agency
The detection of a new case of Ebola in Sierra Leone over the weekend after the West African country had marked almost three weeks of zero cases has prompted the use of an experimental vaccine to fight the disease, according to the United Nations World Health Organization (WHO). (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - September 1, 2015 Category: Global & Universal Source Type: news

Sierra Leone: Guinea Ring Vaccination Trial Extended to Sierra Leone to Vaccinate Contacts of New Ebola Case
[Concord] Freetown, Sierra Leone - September 1, 2015: Detection of a new case of Ebola virus disease in Kambia, Sierra Leone after the country had marked almost three weeks of zero cases has set in motion the first 'ring vaccination' use of the experimental Ebola vaccine in Sierra Leone. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 1, 2015 Category: African Health Source Type: news

Research Using Fetal Tissue
Hello HuffPo! Some of you may know me from junkscience.com or healthnewsdigest.com. My main focus here will be on science, or what passes for science these days. Many people of good will are not aware that our government spends more than $400 billion per year on R & D. Regrettably, a substantial amount of that ends of being little more than a form of academic welfare, for research that has almost no chance of ever leading to anything practical, and in many cases does not even add to so-called "basic knowledge." By way of example (and I will have many more), let's take a look at a current hot topic: Research u...
Source: Science - The Huffington Post - September 1, 2015 Category: Science Source Type: news

Guinea ring vaccination trial extended to Sierra Leone to vaccinate contacts of new Ebola case
Detection of a new case of Ebola virus disease in Kambia, Sierra Leone, after the country had marked almost 3 weeks of zero cases has set in motion the first "ring vaccination" use of the experimental Ebola vaccine in Sierra Leone. The source of Ebola virus transmission is being investigated and all the people who may have been in contact with the infected person are being traced. (Source: WHO news)
Source: WHO news - August 31, 2015 Category: Global & Universal Tags: ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola Source Type: news

Innovations in Science: The Cuban Research Connection
On July 20, 2015 the governments of the United States and Cuba officially re-established diplomatic ties by opening embassies in Washington DC and Havana, after a 55 year embargo initiated by the Kennedy Administration in 1960. The full impact of US re-engagement with Cuba has yet to be determined, but two business sectors have been quick to take advantage of this nascent relationship: travel and academia. While there are still travel restrictions between the two countries, direct US to Cuba flights are already being offered through JetBlue and others will no doubt follow suit, as will the major hotel chains. It's also go...
Source: Science - The Huffington Post - August 26, 2015 Category: Science Source Type: news

Sierra Leone: Guinea Extends Ebola Vaccine Trial to Sierra Leone
[Sierra Leone Government] Freetown -The Guinean Ebola Ring Vaccine Trial has been extended to Sierra Leone as a move to stop the transmission across the region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 26, 2015 Category: African Health Source Type: news

The Ebola virus vaccine is effective. But the fight goes on
The President of Guinea, Mr Alpha Condé, stresses that the Ebola vaccine is 100% effective, as the trial had shown. But the fight should go on. It is necessary to move quickly towards full-scale production of the vaccine to benefit the whole population. (Source: WHO news)
Source: WHO news - August 17, 2015 Category: Global & Universal Tags: ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola Source Type: news

U.S. Scientists Speak Out About The Need For Fetal Tissue In Research
BOSTON (AP) -- The furor on Capitol Hill over Planned Parenthood has stoked a debate about the use of tissue from aborted fetuses in medical research, but U.S. scientists have been using such cells for decades to develop vaccines and seek treatments for a host of ailments, from vision loss to cancer and AIDS. Anti-abortion activists triggered the uproar by releasing undercover videos of Planned Parenthood officials that raised questions of whether the organization was profiting from the sale of fetal tissue. Planned Parenthood has denied making any profit and said it charges fees solely to cover its costs. University labor...
Source: Science - The Huffington Post - August 11, 2015 Category: Science Source Type: news

Fetal Tissue Remains Essential, Medical Researchers Say
BOSTON (AP) — The furor on Capitol Hill over Planned Parenthood has stoked a debate about the use of tissue from aborted fetuses in medical research, but U.S. scientists have been using such cells for decades to develop vaccines and seek treatments for a host of ailments, from vision loss and neurological disorders to cancer and AIDS. Anti-abortion activists set off the uproar by releasing undercover videos of Planned Parenthood officials that raised questions of whether the organization was profiting from the sale of fetal tissue. Planned Parenthood has denied making any profit and said it charges fees solely to cov...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 11, 2015 Category: Consumer Health News Authors: nealjriley Tags: Health Local News fetal tissue Massachusetts General Hospital planned parenthood Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include appropriate therapy for those with atrial fibrillation and have also had stents placed, an Ebola vaccine, helping blind people overcome insomnia, and the benefits of oral contraceptives (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 8, 2015 Category: Cardiology Source Type: news

Single dose of Ebola vaccine works rapidly in monkeys
A single dose of an experimental vaccine protects macaques within seven days from infection with the strain of Ebola virus currently sickening people in western Africa, researchers have found, and it begins to confer some protection against the virus within as few as three days. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - August 7, 2015 Category: Science Authors: Eryn Brown Source Type: news

Single dose Ebola vaccine is safe, effective in monkeys against outbreak strain
A single dose of an experimental Ebola virus vaccine completely protects cynomolgus macaques against the current EBOV outbreak strain, EBOV-Makona, when given at least seven days before exposure, and partially protects them if given three days prior, scientists report. The live-attenuated vaccine, VSV-EBOV, uses genetically engineered vesicular stomatitis virus to carry an EBOV gene that has safely induced protective immunity in macaques. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 6, 2015 Category: Science Source Type: news

Matter: For Vaccines Needed in an Epidemic, Timing is Everything
Waiting to develop a vaccine until an epidemic is raging means waiting too long for it to be proved safe and effective, say scientists who are proposing a global vaccine fund. (Source: NYT Health)
Source: NYT Health - August 6, 2015 Category: Consumer Health News Authors: CARL ZIMMER Tags: Drugs (Pharmaceuticals) Ebola Virus Medicine and Health Vaccination and Immunization MERS (Middle East Respiratory Syndrome) Source Type: news

Single dose Ebola vaccine is safe and effective in monkeys against outbreak strain
(NIH/National Institute of Allergy and Infectious Diseases) NIH scientists report that a single dose of an experimental Ebola virus vaccine completely protects cynomolgus macaques against the current EBOV outbreak strain, EBOV-Makona, when given at least seven days before exposure, and partially protects them if given three days prior. The live-attenuated vaccine, VSV-EBOV, uses genetically engineered vesicular stomatitis virus to carry an EBOV gene that has safely induced protective immunity in macaques. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 6, 2015 Category: Infectious Diseases Source Type: news

Vaccine protects against Ebola when administered 7 days ahead
(American Association for the Advancement of Science) In the face of the recent Ebola outbreak, some good news emerges: a preclinical study testing the efficacy of the Ebola vaccine VSV-EBOV against the newly emerged West African Ebola strain shows complete protection when administered seven days before infection in nonhuman primates, and partial protection when administered three days before infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 6, 2015 Category: Infectious Diseases Source Type: news

End Of Ebola? No. Why We Can't Prevent Outbreaks
Why we need more than an effective vaccine and immununization strategy to stop future epidemics (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 5, 2015 Category: Pharmaceuticals Authors: JV Chamary Source Type: news

There's A Simple Way To Get Skeptical Parents To Vaccinate
Vaccination rates are at an all-time low in some pockets of the U.S., due to a seemingly intractable anti-vaccination sentiment among some parents. This is a major risk to the public safety, but doctors struggle to make headway because medical evidence doesn't seem to assuage these parents' concerns.   So far, most strategies have focused on refuting the myth that vaccines can cause autism. But a new study suggests that confronting parents about the "wrongness" of their views is probably a dead end. Instead, showing parents images of and personal testimonies about infectious diseases seemed to impr...
Source: Science - The Huffington Post - August 5, 2015 Category: Science Source Type: news

Africa: Ebola Vaccine Co-Creator Explains Research
[Ebola Deeply] John-Arne Rottingen, the director of the Division of Infectious Disease Control at the Norwegian Institute of Public Health, is one of the co-creators of the successful Ebola vaccine trial. He worked alongside the Wellcome Trust, the government of Canada, MSF, the London School of Hygiene and Tropical Medicine and manufacturers Merck and NewLink. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 5, 2015 Category: African Health Source Type: news

Ebola research shows the value of vaccines
Clinical science is catching up with the West African Ebola outbreak that has killed more than 11,000 people since last year in countries such as Guinea, Sierra Leone and Liberia. (Source: CNN.com - Health)
Source: CNN.com - Health - August 5, 2015 Category: Consumer Health News Source Type: news

That New Ebola Vaccine Is Related To The Rabies Virus. So Why Is It Safe?
All you need to know about rVSV-ZEBOV, the experimental vaccine against Ebola virus disease (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 4, 2015 Category: Pharmaceuticals Authors: JV Chamary Source Type: news

The New Ebola Vaccine Is Related To Rabies. Is It Safe?
All you need to know about rVSV-ZEBOV, the experimental vaccine against Ebola virus disease (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 4, 2015 Category: Pharmaceuticals Authors: JV Chamary Source Type: news

Ebola Vaccine Candidate Promising (CME/CE)
(MedPage Today) -- Interim results suggest 100% protection (Source: MedPage Today Emergency Medicine)
Source: MedPage Today Emergency Medicine - August 4, 2015 Category: Emergency Medicine Source Type: news

Guinea: The Ebola Vaccine - Seven Things to Understand About rVSV-ZEBOV
[Ebola Deeply] A trial of the rVSV-ZEBOV Ebola vaccine among 7,651 individuals in Guinea has been found to have a protection rate of 100 percent. The vaccine was developed by Merck, the Wellcome Trust and the governments of Norway and Canada, in conjunction with MSF and the London School of Hygiene and Tropical Medicine. Public health experts are calling for the vaccine to be rolled out immediately. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 4, 2015 Category: African Health Source Type: news

July's top stories: Novavax Ebola trial, Nestlé pregnancy nutrients study
Novavax presented positive data from a Phase I clinical trial of its Ebola GP vaccine, Pfizer commenced the Phase IIb trial of its S. aureus multi-antigen vaccine (PF-06290510), and Nestlé’s to assess the effects of nutrients before and during pregna… (Source: Drug Development Technology)
Source: Drug Development Technology - August 4, 2015 Category: Pharmaceuticals Source Type: news

Experimental Ebola Vaccine Could Stop Virus In West Africa
LONDON (AP) — An experimental Ebola vaccine tested on thousands of people in Guinea seems to work and might help shut down the waning epidemic in West Africa, according to interim results from a study published Friday. There is currently no licensed treatment or vaccine for Ebola, which has so far killed more than 11,000 people in West Africa since the world's biggest outbreak began in the forest region of Guinea last year. Cases have dropped dramatically in recent months in the other two hard-hit countries, Sierra Leone and Liberia. "If proven effective, this is going to be a game-changer," said Dr. Margar...
Source: Healthy Living - The Huffington Post - August 4, 2015 Category: Consumer Health News Source Type: news

HuffPost What's Working Honor Roll: We May Finally Have An Ebola Vaccine That Works
As journalists, we dutifully report on what's going wrong, from scandals and corruption to natural disasters and social problems. But far too often the media fails to show the whole picture, neglecting to tell the stories of what is working. From scientific breakthroughs to successful crime-reduction initiatives, the What’s Working Honor Roll highlights some of the best reporting and analysis, from a range of media outlets, on all the ways people are working toward solutions to some of our greatest challenges.   Wired: At Last, An Ebola Vaccine That Might Actually Work   Ebola shook the world ...
Source: Science - The Huffington Post - August 3, 2015 Category: Science Source Type: news

Scientists hail '100% effective' Ebola vaccine
"Ebola vaccine is 'potential game-changer'," says BBC News, while the Daily Mail cites a "100% effective jab" for the disease. These headlines stem from early results of a trial investigating the effects of an Ebola vaccine during the most recent outbreak of the virus in west Africa.Researchers gave the Ebola virus vaccine to thousands of people in Guinea who'd had close contact with an infected individual – a process called "ring vaccination". Half the sample were given the vaccine immediately, while the other half were given the vaccine after a delay of three weeks.The early results, p...
Source: NHS News Feed - August 3, 2015 Category: Consumer Health News Tags: QA articles Source Type: news

Guinea: Ebola Vaccine Shows 100 Percent Success, WHO Says
[CISA] Geneva -The world will soon be able to protect humans against Ebola the World Health Organization (WHO) has said as data from a trial in Guinea showed a vaccine was "100 percent effective." (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 3, 2015 Category: African Health Source Type: news

West Africa: Ebola Vaccine Shows Huge Promise in the Field
[SciDev.Net] Those fighting Ebola may soon have a major weapon against the virus. An Ebola vaccine has been shown to be "highly efficacious" in protecting against the disease, according to the results of a fast-track clinical trial in Guinea, published in medical journal Th (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 3, 2015 Category: African Health Source Type: news

The Ebola vaccine we dared to dream of is here | Jeremy Farrar
A success rate of 100% in trials is spectacular. There is no excuse for inertia on other diseases nowFor more than a year and a half, three of the world’s poorest countries have struggled against the most devastating Ebola epidemic in human history. Containing this unprecedented outbreak would have been a huge challenge for Guinea, Liberia and Sierra Leone under any conditions. But the scale of the task was far greater because of the absence of the most effective possible defence: a vaccine.That may all be about to change. I normally like to avoid superlatives when describing the interim results of a medical tri...
Source: Guardian Unlimited Science - August 3, 2015 Category: Science Authors: Jeremy Farrar Tags: Ebola World news Africa Sierra Leone Guinea Liberia Health Society Infectious diseases Medical research Microbiology Science Vaccines and immunisation Source Type: news

Ebola Vaccine Effective in Phase III Trial (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH A new Ebola vaccine "might be highly efficacious," according to interim results of an open label, phase III trial published in the Lancet … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 3, 2015 Category: Primary Care Source Type: news

Ebola publications: Vaccines, research and development
(Source: WHO news on Ebola)
Source: WHO news on Ebola - August 3, 2015 Category: Infectious Diseases Tags: ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola Source Type: news

Experimental Ebola vaccine up to 100% effective
A single dose of an experimental vaccine was up to 100% effective at preventing Ebola infection among those who had come into contact with recently infected individuals, according to interim results of an open-label trial conducted earlier this year in Guinea. The study, which took place during an...googletag.display('div-gpt-ad-cta'); (Source: Skin and Allergy News)
Source: Skin and Allergy News - August 1, 2015 Category: Dermatology Source Type: news

West Africa: Ebola Vaccine - Reason to Be Hopeful?
[IRIN] Dakar -News that an Ebola vaccine trialled in Guinea has proved 100 percent effective has elicited both excitement and caution from a range of actors closely involved in the outbreak, which also struck Liberia and Sierra Leone and has claimed more than 11,000 lives since March 2014. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 1, 2015 Category: African Health Source Type: news

Medical News Today: First ever successful field testing of Ebola vaccine reported
The vaccine rVSV-ZEBOV has proven to be successful at halting the spread of the Ebola virus in ongoing field tests conducted in Guinea. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 1, 2015 Category: Consumer Health News Tags: Ebola Source Type: news

West Africa: WHO Announces Possible 'Game Changer' Vaccine
[UN News] Having achieved its "core objective" of scaling up global action to tackle the Ebola outbreak in West Africa, the United Nations Mission for Ebola Emergency Response will officially wind down today, transferring its role to the World Health Organization (WHO), which just announced that an experimental vaccine being tested in Guinea appears to be highly effective and could be a "game changer." (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 1, 2015 Category: African Health Source Type: news

West Africa: Call to Boost Use of New Ebola Vaccine
[Ebola Deeply] As health experts hail the VSV-EBOV vaccine study a turning point, MSF's medical director Bertrand Draguez calls for accelerated use of the vaccine in the affected countries. The vaccine was found to be 100 percent effective in a study of about 4000 people in Guinea. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 1, 2015 Category: African Health Source Type: news

WHO Says Ebola Vaccine Possibly Effective in Trial
European researchers said an experimental Ebola vaccine tested in Guinea “might be effective” in protecting people from the deadly virus, but questions have been raised about the way the study was conducted. (Source: WSJ.com: Health)
Source: WSJ.com: Health - August 1, 2015 Category: Pharmaceuticals Tags: PAID Source Type: news

Ebola vaccine trial proves 100% successful in Guinea
Rapid development and testing of drug may bring current epidemic in west Africa to an end and control future outbreaks, experts sayA vaccine against Ebola has been shown to be 100% successful in trials conducted during the outbreak in Guinea and is likely to bring the west African epidemic to an end, experts say.The results of the trials involving 4,000 people are remarkable because of the unprecedented speed with which the development of the vaccine and the testing were carried out. Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 31, 2015 Category: Science Authors: Sarah Boseley Health editor Tags: Ebola Medical research Guinea World news Africa Science Global development Source Type: news

Ebola Vaccine Hailed As 'Game Changer' In Fight Against The Virus
In a small trial, an experimental vaccine protected 100 percent of people at high risk for Ebola. But more data are needed to figure out exactly how well the vaccine works.» E-Mail This (Source: NPR Health and Science)
Source: NPR Health and Science - July 31, 2015 Category: Consumer Health News Authors: Michaeleen Doucleff Source Type: news

One Year Later, Emory's Medical Staff Looks Back On The Ebola Crisis
When Dr. Kent Brantly contracted Ebola during a medical mission to treat others with the disease in Liberia last summer, the U.S. State Department gave Emory University Hospital 72 hours notice before transferring Brantly into their doctors' care. "The first question was: Did we have the ability to care for these patients?" said Nancye Feistritzer, chief nursing officer of the hospital, as she reflected on the experience in the video above. "The second question was: Could we do it safely? "If the answer to both of those were yes," she added, "then it was really not a question of whether w...
Source: Healthy Living - The Huffington Post - July 31, 2015 Category: Consumer Health News Source Type: news

WHO: Ebola vaccine highly effective in trial
A newly developed vaccine against the deadly Ebola virus is "highly effective" and could help prevent its spread in the current and future outbreaks, the World Health Organization said Friday. Trials of the single-dose VSV-EBOV vaccine began in March ... (Source: WDSU.com - Health)
Source: WDSU.com - Health - July 31, 2015 Category: Consumer Health News Source Type: news

Ebola vaccine highly effective in Guinea trial
An experimental vaccine tested in more than 7,500 people in Guinea was highly protective against Ebola in a preliminary analysis. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - July 31, 2015 Category: Science Authors: Eryn Brown Source Type: news

Ebola: A promising vaccine
Dr Bertrand Draguez tells us what an effective Ebola vaccine means for the fight against the disease. (Source: MSF News)
Source: MSF News - July 31, 2015 Category: Global & Universal Authors: Nick Source Type: news

Ebola: UN emergency response mission winds down as WHO announces possible ‘game changer’ vaccine
Having achieved its “core objective” of scaling up global action to tackle the Ebola outbreak in West Africa, the United Nations Mission for Ebola Emergency Response will officially wind down today, transferring its role to the World Health Organization (WHO), which just announced that an experimental vaccine being tested in Guinea appears to be highly effective and could be a “game changer.” (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - July 31, 2015 Category: Global & Universal Source Type: news

Vaccine Success Holds Hope for End to Deadly Scourge of EbolaVaccine Success Holds Hope for End to Deadly Scourge of Ebola
The world is on the verge of being able to protect humans against Ebola, the World Health Organization said on Friday, as a trial in Guinea found a vaccine to have been 100% effective. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 31, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

​Merck should follow GSK’s lead and commit to selling its potential Ebola vaccine at cost
Between disease names that few people have ever heard of and scientific jargon, it’s rare for the results of a drug trial to make for an easily understandable headline. That was not the case this morning when Reuters reported a story headline, “ Merck’s Ebola vaccine proves fully effective in Guinea trial.” Everyone knows Ebola. That’s the disease in Africa that’s killed more than 11,000 people since December 2013, and made some people freak out last fall because President Barack Obama… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2015 Category: Pharmaceuticals Authors: Don Seiffert Source Type: news